Neurofibroma — Trials

Neurofibroma — Trials · CancerIndex

Clinical trials

Registered studies

55 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05891847	Non-interventional Study of Patients With PN NF1 Starting Selumetinib in Russia	terminated	—	150	AstraZenecaINDUSTRY	1	Jul 8, 2026	clinicaltrials
NCT00326872	AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine	terminated	Phase 2	26	National Cancer Institute (NCI)NIH	1	Aug 18, 2017	clinicaltrials